全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Journal of Blood Medicine

ISSN Print: 1179-2736

ISSN Online:

主页: https://www.dovepress.com/journal-of-blood-medicine-journal

分享:




Go

Biomarkers for the differentiation of anemia and their clinical usefulness

Northrop-Clewes CA, Thurnham DI

Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia

Widjajanto PH, Sumadiono S, Cloos J, Purwanto I, Sutaryo S, Veerman AJP

Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia

Widjajanto PH,Sumadiono S,Cloos J,Purwanto I

Public banking of umbilical cord blood or storage in a private bank: testing social and ethical policy in northeastern Italy

Parco S,Vascotto F,Visconti P

Beta-amyloidolysis and glutathione in Alzheimer's disease

Lasierra-Cirujeda J,Coronel P,Aza MJ,Gimeno M

Biomarkers for the differentiation of anemia and their clinical usefulness

Northrop-Clewes CA,Thurnham DI

First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation

Piccaluga PP, Paolini S, Bertuzzi C, De Leo A, Rosti G

Optimal management of pernicious anemia

Andres E, Serraj K

Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia

Baran Y, Saydam G

Treatments for chronic myeloid leukemia: a qualitative systematic review

Ferdinand R, Mitchell SA, Batson S, Tumur I

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K

Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?

Barton Pai A, Garba AO

Spontaneous resolution of macrocytic anemia: old disease revisited

Imashuku S, Kudo N, Kaneda S

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)

Young G, Solem CT, Hoffman K, Kabawat J, Pickard AS, Gut RZ, Cooper DL

Treating thalassemia major-related iron overload: the role of deferiprone

Berdoukas V, Farmaki K, Carson S, Wood J, Coates T

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors

Saba HI, Tran DQ Jr

Erratum

Yeung J, Holinstat M

Barriers in transition from pediatrics to adult medicine in sickle cell anemia

Lebensburger JD, Bemrich-Stolz CJ, Howard TH

Determination of reference ranges for full blood count parameters in neonatal cord plasma in Hilla, Babil, Iraq

Al-Marzoki JM, Al-Maaroof ZW, Kadhum AH

Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives

Petrini C

Newer agents in antiplatelet therapy: a review

Yeung J, Holinstat M

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal

Kapoor S

Letter to the editor

D'Alessandro V, Greco M

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants

Jhawar MB, Flaker G

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis

Mikhail A

First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation

Piccaluga PP,Paolini S,Bertuzzi C,De Leo A

Barriers in transition from pediatrics to adult medicine in sickle cell anemia

Lebensburger JD,Bemrich-Stolz CJ,Howard TH

Treatments for chronic myeloid leukemia: a qualitative systematic review

Ferdin,R,Mitchell SA,Batson S

Erratum

Yeung J,Holinstat M

Determination of reference ranges for full blood count parameters in neonatal cord plasma in Hilla, Babil, Iraq

Al-Marzoki JM,Al-Maaroof ZW,Kadhum AH

Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia

Baran Y,Saydam G

Spontaneous resolution of macrocytic anemia: old disease revisited

Imashuku S,Kudo N,Kaneda S

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)

Young G,Solem CT,Hoffman K,Kabawat J

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis

Mikhail A

Treating thalassemia major-related iron overload: the role of deferiprone

Berdoukas V,Farmaki K,Carson S,Wood J

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal

Kapoor S

Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives

Petrini C

Optimal management of pernicious anemia

Andres E,Serraj K

Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?

Barton Pai A,Garba AO

Newer agents in antiplatelet therapy: a review

Yeung J,Holinstat M

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

Imashuku S,Kudo N,Kubo K,Saigo K

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants

Jhawar MB,Flaker G

Letter to the editor

D'Alessandro V,Greco M

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors

Saba HI,Tran DQ Jr

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia

Sandro Eridani, Andrea Mosca

Role of ofatumumab in treatment of chronic lymphocytic leukemia

Veliz M, Pinilla-Ibarz J

The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood

Erhabor Osaro, Adias Teddy Charles

Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies

LeAnne D Kennedy, Susannah Koontz, Kamakshi Rao

Treatment of patients with von Willebrand disease

Tuohy E, Litt E, Alikhan R

Deep vein thrombosis: a clinical review

Kesieme EB, Kesieme CN, Jebbin N, Irekpita E, Dongo A

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705